You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Esophageal Carcinoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Endoscopic Submucosal Dissection Versus Esophagectomy for Early

Completed
  • Esophageal Cancer
  • Endoscopic submucosal dissection
  • Esophagectomy
  • Shanghai, China
    Changhai Hospital, Naval Medical University
Sep 27, 2023

Esophageal Carcinoma Trial (Immune Checkpoint Inhibitors)

Not yet recruiting
  • Esophageal Carcinoma
  • Immune Checkpoint Inhibitors
  • (no location specified)
Jul 6, 2023

Esophageal Carcinoma, Neoadjuvant Therapy Trial (Toripalimab, Anlotinib HCl, Albumin paclitaxel)

Not yet recruiting
  • Esophageal Carcinoma
  • Neoadjuvant Therapy
  • (no location specified)
Aug 16, 2023

Advanced Solid Tumor Trial (HS-20093)

Not yet recruiting
  • Advanced Solid Tumor
  • (no location specified)
Oct 29, 2023

Esophageal Carcinoma, Neoadjuvant Immunotherapy Trial in Beijing (PD-1 blockade, Albumin paclitaxel, Carboplatin/Nedaplatin)

Recruiting
  • Esophageal Carcinoma
  • Neoadjuvant Immunotherapy
  • PD-1 blockade
  • +2 more
  • Beijing, Beijing, China
    Qin li
Mar 8, 2023

Chemo, Radiation Therapy Trial in Fuzhou (Camrelizumab, Paclitaxel, Cisplatin)

Not yet recruiting
  • Chemotherapy
  • Radiation Therapy
  • Fuzhou, China
    Fujian Medical University Union Hospital
Apr 6, 2023

Esophageal Carcinoma Trial in Nanjing (Nimotuzumab, Tigio, Concurrent radiation therapy)

Enrolling by invitation
  • Esophageal Carcinoma
  • Nanjing, Jiangsu, China
    The First Affiliated Hospital of Nanjing Medical University
Sep 19, 2023

Nivolumab in Treatment of Early Stage Esophageal or

Not yet recruiting
  • Esophageal Carcinoma
  • Gastroesophageal Junction Carcinoma
    • Louisville, Kentucky
    • +2 more
    Mar 21, 2023

    EsophaCap for the Detection of Early Esophageal Carcinoma

    Recruiting
    • Barrett Esophagus
    • +2 more
      • Baltimore, Maryland
      • +1 more
      Dec 8, 2022

      Esophageal Carcinoma Trial in Shijiazhuang (toripalimab)

      Recruiting
      • Esophageal Carcinoma
      • Shijiazhuang, Hebei, China
        Fourth Hospital of Hebei Medical University
      Aug 20, 2023

      Minimally Residual of Esophageal Cancer 001

      Recruiting
      • Esophageal Carcinoma
      • Minimal Residual Disease
        • Shijiazhuang, Hebei, China
          Fourth Hospital of Hebei Medical University
        Jul 17, 2023

        Metastatic Esophageal Squamous Cell Carcinoma Trial in Qingdao (TP regimen (cis-platinum ; Tocetaxel ) combined with PD-1

        Recruiting
        • Metastatic Esophageal Squamous Cell Carcinoma
        • TP regimen (cis-platinum ; Tocetaxel ) combined with PD-1 inhibitors（Sintilimab）
        • Qingdao, Shandong, China
        • +1 more
        Nov 13, 2023

        Atrial Fibrillation, Esophageal Carcinoma Trial in Portland (Amiodarone Hydrochloride, Saline)

        Not yet recruiting
        • Atrial Fibrillation
        • Esophageal Carcinoma
        • Amiodarone Hydrochloride
        • Saline
        • Portland, Oregon
          OHSU Knight Cancer Institute
        Sep 28, 2023

        Advanced Esophageal Squamous Carcinoma With Oligometastases Trial (simultaneous with radiotherapy, synchronous with

        Not yet recruiting
        • Advanced Esophageal Squamous Carcinoma With Oligometastases
        • simultaneous with radiotherapy
        • synchronous with radiotherapy
        • (no location specified)
        Nov 16, 2023

        Esophageal Squamous Cell Carcinoma Trial in Shanghai (Sintilimab, Chemotherapy)

        Not yet recruiting
        • Esophageal Squamous Cell Carcinoma
        • Shanghai, Shanghai, China
          Fudan University Shanghai Cancer Center
        Nov 30, 2023

        Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma

        Recruiting
        • Esophageal Squamous Cell Carcinoma
          • Shijiazhuang, Hebei, China
            Department of Thoracic Surgery, Fourth Hospital of Hebei Medical
          Oct 25, 2023

          Esophageal Squamous Cell Carcinoma Trial in Wuhan (no intervention)

          Recruiting
          • Esophageal Squamous Cell Carcinoma
          • no intervention
          • Wuhan, Hubei, China
            Renmin hosptial of Wuhan University
          Jul 29, 2023

          Esophageal Cancer, Esophageal Squamous Cell Carcinoma, Esophageal Squamous Cell Carcinoma by AJCC V8 Stage Trial (LBL-007,

          Not yet recruiting
          • Esophageal Cancer
          • +2 more
          • (no location specified)
          Aug 21, 2023

          Neoadjuvant Chemotherapy Compared With Surgery for Esophageal

          Completed
          • Esophagus Cancer
          • Paclitaxel- and platinum-based chemotherapy
          • Zhengzhou, Henan, China
            Henan Cancer Hospital (The Affiliated Cancer Hospital of Zhengzh
          Oct 5, 2022

          NLR and Its Association With Efficacy of Immunochemotherapy in

          Recruiting
          • Esophageal Squamous Cell Carcinoma
          • +2 more
            • Guangzhou, Guangdong, China
              Guangdong Provincial People's Hospital
            Nov 10, 2023

            Esophageal Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma Trial in Chengdu (Camrelizumab, Dalpiciclib 100mg,

            Recruiting
            • Esophageal Squamous Cell Carcinoma
            • Head and Neck Squamous Cell Carcinoma
            • Chengdu, Sichuan, China
              West China Hospital, Sichuan University
            Oct 25, 2023

            Esophageal Squamous Cell Carcinoma Trial in Shanghai (Tirelizumab, Nab paclitaxel, Carboplatin)

            Recruiting
            • Esophageal Squamous Cell Carcinoma
            • Shanghai, Shanghai, China
              Ruijin hospital, Shanghai jiaotong university school of medicine
            Nov 6, 2023

            Esophageal Squamous Cell Carcinoma Trial (Fruquintinib Combined With Camrelizumab, Paclitaxel Liposome and Nedaplatin)

            Not yet recruiting
            • Esophageal Squamous Cell Carcinoma
            • Fruquintinib Combined With Camrelizumab, Paclitaxel Liposome and Nedaplatin
            • (no location specified)
            Aug 17, 2023

            Esophageal Squamous Cell Carcinoma Trial (LY01015, Fluorouracil, Cisplatin)

            Not yet recruiting
            • Esophageal Squamous Cell Carcinoma
            • (no location specified)
            Aug 28, 2023

            Esophageal Squamous Cell Carcinoma, Esophageal Cancer, Metastatic Esophageal Squamous Cell Carcinoma Trial in Shanghai

            Recruiting
            • Esophageal Squamous Cell Carcinoma
            • +2 more
            • LDRT+CFRT
            • +2 more
            • Shanghai, China
            • +1 more
            Aug 3, 2023